PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $203,000 | +91.5% | 325,573 | +37.2% | 0.00% | – |
| Q2 2016 | $106,000 | -21.5% | 237,364 | +84.9% | 0.00% | – |
| Q1 2016 | $135,000 | -60.4% | 128,398 | +11.1% | 0.00% | – |
| Q4 2015 | $341,000 | +196.5% | 115,608 | +218.3% | 0.00% | – |
| Q3 2015 | $115,000 | -59.4% | 36,322 | -23.9% | 0.00% | – |
| Q2 2015 | $283,000 | +5.2% | 47,734 | +89.4% | 0.00% | – |
| Q1 2015 | $269,000 | -34.1% | 25,209 | -42.0% | 0.00% | – |
| Q4 2014 | $408,000 | -67.8% | 43,482 | -73.7% | 0.00% | – |
| Q3 2014 | $1,269,000 | -74.8% | 165,264 | -70.6% | 0.00% | -100.0% |
| Q2 2014 | $5,044,000 | +1598.3% | 561,708 | +913.2% | 0.00% | – |
| Q1 2014 | $297,000 | +145.5% | 55,438 | +15.6% | 0.00% | – |
| Q4 2013 | $121,000 | – | 47,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,010,000 | $905,000 | 0.21% |
| GLOBEFLEX CAPITAL L P | 226,959 | $102,000 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 62,800 | $28,000 | 0.01% |
| MENTA CAPITAL LLC | 195,136 | $87,000 | 0.01% |
| Orbimed Advisors | 1,073,000 | $481,000 | 0.01% |
| GOODWIN DANIEL L | 22,679 | $10,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 215,800 | $97,000 | 0.00% |
| Renaissance Technologies | 2,214,396 | $992,000 | 0.00% |
| STOCK YARDS BANK & TRUST CO | 30,170 | $14,000 | 0.00% |
| HIGHLAND CAPITAL MANAGEMENT, LLC | 41,000 | $18,000 | 0.00% |